News

MyChesCo on MSN19h
Fujirebio Launches sTREM2 Assay to Advance Neuroinflammation Research
H.U. Group Holdings Inc. and its subsidiary Fujirebio have announced the launch of the Lumipulse G sTREM2 assay, a ...
FOX 9 Minneapolis-St. Paul3d
New FDA-approved Alzheimer’s blood test coming to Mayo Clinic
The U.S. Food and Drug Administration has approved the marketing of a new tool to that can test a person’s blood to diagnose ...
ABC Action News4d
Doctor discusses first FDA-cleared blood test to help diagnose Alzheimer's
The Lumipulse test has specifically been approved to help diagnose the disease in the clinical setting. Dr. Amanada Smith ...
First FDA-approved blood test helps early detection of Alzheimer’s
A simple blood draw has now become a powerful tool in the early fight against Alzheimer’s. The FDA has approved the first ...
FDA clears blood test that helps early detection of Alzheimer’s
A simple blood draw has now become a powerful tool in the early fight against Alzheimer’s. The FDA has approved the first ...
Agence France-Presse5d
Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G sTREM2 Assay for Research Use Only
Fujirebio, a member of H.U. Group Holdings Inc., is a global leader in the field of high-quality RUO and in vitro diagnostics (IVD) testing. It has more than 50 years’ accumulated experience in the ...
Mirage News5d
Fujirebio Unveils Lumipulse G STREM2 for Neuro Research
Fujirebio, a member of H.U. Group Holdings Inc., is a global leader in the field of high-quality RUO and in vitro diagnostics (IVD) testing. It has more than 50 years' accumulated experience in the ...